<--- Back to Details
First PageDocument Content
Cytokines / PEGylation / Schering AG / Interferon beta-1b / Interferon / Polyethylene glycol / Management of multiple sclerosis / Multiple sclerosis / Interferon beta-1a / Enzon Pharmaceuticals
Date: 2016-07-11 16:56:19
Cytokines
PEGylation
Schering AG
Interferon beta-1b
Interferon
Polyethylene glycol
Management of multiple sclerosis
Multiple sclerosis
Interferon beta-1a
Enzon Pharmaceuticals

MOUNTAIN VIEW PHARMACEUTICALS

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 22,48 KB

Share Document on Facebook

Similar Documents

2 MarchMaterial Specification Print Sheet Polyethylene Terephthalate Glycol-modified PETG Makergeeks

DocID: 1uV4a - View Document

MIRCERA, INN-methoxy polyethylene glycol-epoetin beta

DocID: 1tjHd - View Document

POLYETHYLENE GLYCOL CONJUGATES OF INTERFERON-BETA-1b WITH ENHANCED IN VITRO BIOLOGICAL POTENCY - European Patent Office - EPB9 POLYETHYLENE GLYCOL CONJUGATES OF INTERFERON-BETA-1b WITH ENHANCED IN

DocID: 1s2aB - View Document

Chemistry / Medicine / Clinical medicine / Excipients / Inborn errors of purine-pyrimidine metabolism / Uric acid / Biotechnology / PEGylation / Pharmacokinetics / Pegloticase / Urate oxidase / Polyethylene glycol

Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1

DocID: 1rrm1 - View Document

Chemistry / Polymer chemistry / Plastics / Polythiophene / Thiophenes / Polymer / Copolymer / Polyethylene glycol / Solvent / Methanol

Microsoft Word - Figures for productions

DocID: 1r98T - View Document